AmerisourceBergen Corporation ABC
Set alert
At close · Aug 29
52-week range unavailable
- Open
- 180.93
- Prev close
- 179.98
- Mkt cap
- 38.69B
- Vol
- 806.05K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 1.02%
More statistics
- Low
- 179.24
- High
- 180.93
- Forward P/E
- 15.03
- Beta
- 0.57
- Short ratio
- 2.74
- Inst. own
- 77.94%
- Dividend
- 1.94
- Ex-div date
- May 10, 2023
- Earnings
- Aug 2, 2023
- 50-d avg
- 178.20
- 200-d avg
- 163.39
- 1y target
- 193.79
5Y chart
Events in this range
- Nov 12, 2021Dividend: 0.46
- Feb 11, 2022Dividend: 0.46
- May 4, 2022Earnings: —; estimate 2.99; surprise —%
- May 13, 2022Dividend: 0.46
- Aug 3, 2022Earnings: —; estimate 2.57; surprise —%
- Aug 12, 2022Dividend: 0.46
- Nov 3, 2022Earnings: —; estimate 2.58; surprise —%
- Nov 10, 2022Dividend: 0.485
- Nov 28, 2022Dividend: 0.485
- Feb 1, 2023Earnings: —; estimate 2.62; surprise —%
- Feb 9, 2023Dividend: 0.485
- May 2, 2023Earnings: —; estimate 3.29; surprise —%
- May 3, 2023Rating: TD Cowen · — → Outperform
- May 3, 2023Rating: Citigroup · — → Buy
- May 11, 2023Dividend: 0.485
- May 26, 2023Rating: B of A Securities · — → Buy
- May 26, 2023Rating: UBS · — → Buy
- Jun 7, 2023Rating: B of A Securities · Buy → Buy
- Jul 11, 2023Rating: Mizuho · Neutral → Neutral
- Aug 2, 2023Earnings: —; estimate 2.83; surprise —%
- Aug 10, 2023Dividend: 0.485
Signals (34)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 25, 2023 | 3 years ago |
| SMA: Bullish | Sep 12, 2023 | 3 years ago |
| SMA: Bearish | Sep 5, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 22, 2023 | 3 years ago |
| SMA: Bearish | Aug 8, 2023 | 3 years ago |
| RSI: Overbought | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 6, 2023 | 3 years ago |
| SMA: Bearish | May 30, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 18, 2023 | 3 years ago |
| SMA: Bullish | Mar 28, 2023 | 3 years ago |
| SMA: Bullish | Mar 21, 2023 | 3 years ago |
| SMA: Bearish | Mar 7, 2023 | 3 years ago |
| SMA: Bearish | Feb 7, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 7, 2023 | 3 years ago |
| SMA: Bullish | Jan 31, 2023 | 3 years ago |
| SMA: Bearish | Jan 17, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 15, 2022 | 4 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jul 1, 2022 | 4 years ago |
| SMA: Bullish | Jun 27, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 27, 2022 | 4 years ago |
| SMA: Bearish | May 16, 2022 | 4 years ago |
| SMA: Bullish | May 9, 2022 | 4 years ago |
| SMA: Bearish | May 2, 2022 | 4 years ago |
| RSI: Overbought | Feb 28, 2022 | 4 years ago |
Key statistics
- Market cap
- 38.69B
- Enterprise value
- 44.07B
- Trailing P/E
- 24.59
- Forward P/E
- 15.03
- PEG ratio
- 2.02
- Price / sales
- 0.16
- Price / book
- 137.41
- EPS (TTM)
- 7.78
- Beta
- 0.57
- Dividend yield
- 1.02%
- Payout ratio
- 24.26%
- Profit margin
- 0.65%
- Revenue (TTM)
- 247.54B
- Revenue growth
- 9.90%
- Free cash flow
- 3.67B
- Total cash
- 1.54B
- Total debt
- 6.26B
- Return on equity
- 221.04%
- Shares outstanding
- 202.26M
- Short % of float
- 2.57%
- 50-day average
- 178.20
- 200-day average
- 163.39
Analyst view
Consensus: buy
- Target (low)
- 172.00
- Target (mean)
- 193.79
- Target (high)
- 213.00
- Strong buy3
- Buy3
- Hold8
- Sell0
- Strong sell0
Next earnings
Aug 2, 2023
Expected Aug 2, 2023. Consensus EPS estimate 2.82.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 2, 2023 | Jun 1, 2023 | 2.83 | — | — | — |
| May 2, 2023 | Mar 1, 2023 | 3.29 | — | — | — |
| Feb 1, 2023 | Dec 1, 2022 | 2.62 | — | — | — |
| Nov 3, 2022 | Sep 1, 2022 | 2.58 | — | — | — |
| Aug 3, 2022 | Jun 1, 2022 | 2.57 | — | — | — |
| May 4, 2022 | Mar 1, 2022 | 2.99 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 11, 2023 | Mizuho | main | Neutral | Neutral |
| Jun 7, 2023 | B of A Securities | main | Buy | Buy |
| May 26, 2023 | UBS | main | — | Buy |
| May 26, 2023 | B of A Securities | reit | — | Buy |
| May 3, 2023 | Citigroup | main | — | Buy |
| May 3, 2023 | TD Cowen | main | — | Outperform |
About AmerisourceBergen Corporation
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- amerisourcebergen.com
News
- Disney's multiplatform Super Bowl plan frustrates ABC affiliates
- Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline
- Anthropic pushes for opt-out model for Australian content as ABC warns of ‘cannibalisation' of news
- ABC's Jimmy Kimmel Takes Aim at FCC Over Equal-Time Rules
- ABC's Kimmel says interview with Senate candidate Talarico will stream on YouTube amid FCC threats
- US FCC asks court to reject Disney lawsuit over ABC TV station licenses
- Disney's ABC Sues FCC And Can Lean On Decades Of Deregulation
- ABC Local Station Move Draws FCC Scrutiny
- Now Streaming: Paramount says it satisfied regulatory approvals for Warner deal
- ABC says intimidation by Trump's FCC forced programming changes
Your note
Sign in to keep a note on ABC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATTAGLIA SILVANA | Officer | Stock Award(Grant) | Jun 29, 2023 | 11,778 |
| CAMPBELL ELIZABETH S | Officer | Stock Award(Grant) | Jun 29, 2023 | 11,955 |
| CLARK GINA K. | Officer | Sale | Jun 21, 2023 | 26,733 |
| CLEARY JAMES F. JR. | Chief Financial Officer | Conversion of Exercise of derivative security | May 17, 2023 | 81,665 |
| COLLIS STEVEN H | Chief Executive Officer | Sale | Jul 10, 2023 | 257,967 |
| DONATO LESLIE E. | Officer | Conversion of Exercise of derivative security | Jun 29, 2023 | 7,049 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 10.42% | 21,077,025 | 4.03B | Mar 30, 2023 |
| Blackrock Inc. | 8.44% | 17,072,715 | 3.27B | Mar 30, 2023 |
| Price (T.Rowe) Associates Inc | 5.07% | 10,257,332 | 1.96B | Mar 30, 2023 |
| State Street Corporation | 3.67% | 7,419,026 | 1.42B | Mar 30, 2023 |
| JP Morgan Chase & Company | 3.46% | 7,002,190 | 1.34B | Mar 30, 2023 |
| Boston Partners | 2.48% | 5,011,154 | 958.53M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.47% | 4,999,020 | 956.21M | Dec 30, 2022 |
| Vanguard Mid-Cap Index Fund | 1.89% | 3,830,605 | 732.72M | Dec 30, 2022 |
| Vanguard 500 Index Fund | 1.85% | 3,743,980 | 716.15M | Dec 30, 2022 |
| JP Morgan Equity Income Fund | 1.04% | 2,107,199 | 403.07M | Dec 30, 2022 |
| Fidelity 500 Index Fund | 0.88% | 1,775,417 | 339.60M | Feb 27, 2023 |
| John Hancock Fds III-Disciplined Value Mid Cap Fd | 0.87% | 1,757,942 | 336.26M | Feb 27, 2023 |